John W. Brooker & Co’s Viatris VTRS Stock Holding History

John W. Brooker & Co’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	–	–	186
2022 Q3	$0	Hold	8	–	–	﹤0.01%	201
2022 Q2	$0	Hold	8	–	–	﹤0.01%	198
2022 Q1	$0	Hold	8	–	–	﹤0.01%	202
2021 Q4	$0	Hold	8	–	–	﹤0.01%	207
2021 Q3	$0	Hold	8	–	–	﹤0.01%	206
2021 Q2	$0	Hold	8	–	–	﹤0.01%	202
2021 Q1	$0	Hold	8	–	–	﹤0.01%	180
2020 Q4	$0	Buy	+8	New	+$130	﹤0.01%	171

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

John W. Brooker & Co's VTRS Position: Q4 2022 in Review

John W. Brooker & Co sold out of Viatris (VTRS) in Q4 2022, closing a stake of 8 shares.

John W. Brooker & Co first reported a position in VTRS in Q4 2020 and held it in 8 quarters. The position peaked at $0 in Q3 2022. 1,015 funds tracked by Wall St. Rank hold VTRS as of Q4 2022.

John W. Brooker & Co reported no remaining Viatris position as of Q4 2022 after selling out during the quarter.
John W. Brooker & Co sold 8 Viatris shares in Q4 2022.
John W. Brooker & Co first reported a position in Viatris in Q4 2020 and held it in 8 quarters.
John W. Brooker & Co's Viatris position peaked at $0 in Q3 2022.
1,015 funds tracked by Wall St. Rank held Viatris as of Q4 2022.

Based on John W. Brooker & Co's 13F filing for Q4 2022, filed 13 Jan 2023.